Identification of 11,13-dihydroxy-14-octadecaenoic acid as a circulating Na+/K+-ATPase inhibitor

in Journal of Endocrinology
Authors:
D. Lichtstein
Search for other papers by D. Lichtstein in
Current site
Google Scholar
PubMed
Close
,
S. Samuelov
Search for other papers by S. Samuelov in
Current site
Google Scholar
PubMed
Close
,
I. Gati
Search for other papers by I. Gati in
Current site
Google Scholar
PubMed
Close
,
A. M. Felix
Search for other papers by A. M. Felix in
Current site
Google Scholar
PubMed
Close
,
T. F. Gabriel
Search for other papers by T. F. Gabriel in
Current site
Google Scholar
PubMed
Close
, and
J. Deutsch
Search for other papers by J. Deutsch in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

ABSTRACT

Two digitalis-like compounds (DLC) were purified to homogeneity from bovine plasma. The purification procedure consisted of organic extractions and batch chromatography followed by three subsequent separations using reverse-phase high-performance liquid chromatography. The presence of a DLC in the different fractions was monitored by their ability to inhibit (a) [3H]ouabain binding to rat brain synaptosomes, and (b) microsomal Na+/K+-ATPase activity. Using mass spectrometry and nuclear magnetic resonance spectroscopy the structure of one of the DLCs was identified as 11,13-dihydroxy-14-octadecaenoic acid. It is suggested that this new hydroxy, unsaturated, fatty acid derivative may regulate Na+/K+-ATPase activity under some physiological and pathological conditions.

Journal of Endocrinology (1991) 128, 71–78

 

  • Collapse
  • Expand